Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.
about
Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade gliomaCurrent standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patientsDiffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumorsNuclear overhauser enhancement mediated chemical exchange saturation transfer imaging at 7 Tesla in glioblastoma patientsThe comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkersAdvances in diagnostic and treatment modalities for intracranial tumors.Convex non-negative matrix factorization for brain tumor delimitation from MRSI data.Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T.Advanced magnetic resonance imaging of the physical processes in human glioblastoma.Advanced neuroimaging in the clinic: critical appraisal of the evidence base.Interrogating Metabolism in Brain Cancer.Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapyRadiosurgery for high-grade glioma.Review of treatment assessment using DCE-MRI in breast cancer radiation therapy.Delayed contrast extravasation MRI for depicting tumor and non-tumoral tissues in primary and metastatic brain tumors.Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumabDelayed contrast extravasation MRI: a new paradigm in neuro-oncologyDifferentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-AnalysisWatching tumours gasp and die with MRI: the promise of hyperpolarised 13C MR spectroscopic imaging.Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBMMagnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas.Multivoxel ¹H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targetingSerial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab.Non-invasive in vivo assessment of IDH1 mutational status in glioma.Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastoma.In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells.IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastoma.Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in gliomaMRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas.Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI.A fuzzy feature fusion method for auto-segmentation of gliomas with multi-modality diffusion and perfusion magnetic resonance images in radiotherapy.Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.
P2860
Q26826862-FD9E630C-8D89-4A38-B222-47EE429F86BDQ26853308-FAAE11B8-279F-4792-912B-12EB4DBA2533Q28067114-D6193645-FFBC-4F15-B4BA-5E413F890279Q28541749-28760451-307A-4C65-A481-496784B1A989Q28608269-1985014E-A8F0-4239-B16F-1096574BB86FQ30358150-B9BFA975-E4C0-4EBC-A38D-21240B4EA9D1Q30575323-DC44CD96-B887-49F7-849E-6A3C941245C9Q30613603-361D915B-B8AF-47BE-9C4D-C5398E500413Q30847284-2C8F0410-286D-4EA1-A186-C675BF243C06Q31076319-C08CF3E7-1216-42AB-AC2B-9C5F815EACE5Q31136705-8152D51D-7E3E-44CB-8564-FCD35DBE2C33Q33844943-D6971706-4828-4F01-8DE8-DC8041F4E403Q34280336-50B3B0E5-5D7E-4D0C-8A22-3799AB767A20Q34289982-45E2BDFD-3157-42B9-8704-AB5A1F83BC2FQ34367593-70F516B2-3701-44A0-867B-CCC864C4D692Q34517492-18B33D1D-FE3D-45BA-809C-33237ECB3D44Q35028897-73047491-E429-41D2-BA16-72FF7216F57AQ35788925-93ABD661-4C75-423D-A585-FB59A63446B7Q35888150-BFA1A1C4-955E-4A07-86C5-9A9CD3334C00Q36326284-237E1D8A-FFDE-4036-A998-306C2FDAAE4CQ37014722-2A86CDD3-B434-4AA6-B8A8-C499CE66B56AQ37168287-6F9428D4-CB4D-4562-9F81-AD13FA8554C0Q37312731-D87F5795-5692-4BE4-A9F1-284E83849F53Q37348479-B0023F3A-5237-46E8-86AD-2780E85ADBDFQ37537230-93CD8EF4-DD22-4743-822E-F1FE07B03380Q37609463-A9F5368C-C0D6-456B-8FC6-A230E70370A8Q38680891-3F4D1697-C711-4E6A-B1DF-4F3BA78AF6A9Q38867300-2A9B1648-4622-4D48-A47E-8A8655E99A6EQ38969526-4FADA594-A29F-43BD-9890-D8DA82338AE9Q38990221-DA0B439B-56CB-43AC-8455-7BACF5E863C8Q39312420-678EB1BA-C84C-47AF-898B-EDD6C942D28DQ39817583-1A4091B0-DFC8-4F7F-AB52-37220B8B36DBQ40116790-AD66BF87-3B6A-4A11-AE2C-B629D92DB4B4Q49830313-8FC95B19-5A7C-45DA-92B2-6C4B9DDDE900Q52091021-5E1B56C6-FA17-48C2-AB31-4A2D5C944C7E
P2860
Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Assessment of therapeutic resp ...... tabolic and physiological MRI.
@ast
Assessment of therapeutic resp ...... tabolic and physiological MRI.
@en
type
label
Assessment of therapeutic resp ...... tabolic and physiological MRI.
@ast
Assessment of therapeutic resp ...... tabolic and physiological MRI.
@en
prefLabel
Assessment of therapeutic resp ...... tabolic and physiological MRI.
@ast
Assessment of therapeutic resp ...... tabolic and physiological MRI.
@en
P2860
P356
P1433
P1476
Assessment of therapeutic resp ...... tabolic and physiological MRI.
@en
P2093
Sarah J Nelson
P2860
P304
P356
10.1002/NBM.1669
P577
2011-04-27T00:00:00Z